VMTHF OTC
Venus Medtech (Hangzhou), Inc. Class H
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +57.4%
1Y: -18.8%
3Y: -74.6%
$0.42
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$24M
+103.9% ▲
Capital Expenditures
$42M
+84.2% ▲
5Y CAGR: +21.5%
Free Cash Flow
-$18M
+98.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$476M
+56.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$182M | -$374M | -$858M | -$704M | -$741M |
| Depreciation & Amort. | $38M | $52M | $112M | $125M | $111M |
| Stock-Based Comp. | $9M | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$135M | -$151M | -$130M | -$117M | $310M |
| Other Non-Cash Items | $33M | $16M | $146M | $86M | $344M |
| Operating Cash Flow | -$237M | -$457M | -$729M | -$610M | $24M |
| — Investing Activities — | |||||
| Capital Expenditures | -$124M | -$125M | -$170M | -$261M | -$34M |
| Acquisitions (Net) | -$94M | -$176M | -$813M | -$4M | -$483K |
| Investment Purchases | -$70M | -$420M | -$92M | -$45M | -$426K |
| Investment Sales | $0 | $54M | $0 | $22M | $0 |
| Other Investing | -$9M | $14M | $3M | -$60M | $15M |
| Investing Cash Flow | -$298M | -$653M | -$1.1B | -$347M | -$20M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$130M | -$20M | $702M | -$130M | -$423M |
| Stock Repurchased | $0 | -$73M | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $23M | $293M | -$67M | -$44M | -$64M |
| Financing Cash Flow | $928M | $1.4B | $635M | -$174M | -$487M |
| Net Change in Cash | $295M | $247M | -$1.1B | -$1.1B | -$476M |
| Cash End of Period | $2.7B | $3.0B | $1.9B | $774M | $298M |
| Free Cash Flow | -$361M | -$602M | -$908M | -$873M | -$18M |